|
Hope You Signed Up And Are Making Money!! SRGL,MAPP,SNWT,HLCS,EDWY,BRYN
(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (OTCBB: SRGL) Source Gold Corp., (NASDAQ: MAPP) MAP Pharmaceuticals, Inc., (OTCBB: SNWT) San West, Inc., (NASDAQ: HLCS) Helicos BioSciences Corp., (PINKSHEETS: EDWY) eDOORWAYS Corp., (PINKSHEETS: BRYN) Bryn Resources, Inc.
www.StockMarketingInc.com
To sign up for our free Profiles & Alerts :: visit http://www.StockMarketingInc.com
email us!! info@StockMarketingInc.com or call 1-866-583-8960
---------------------------
(OTCBB: SRGL - Source Gold Corp.)
LATEST NEWS!!
Source Gold Corp. Identifies High Grade Gold and Copper From Initial Sampling Program
CALGARY, ALBERTA, Nov 27, 2009 -- Source Gold Corp. (OTCBB: SRGL) is pleased to announce that the company has received initial results from samples assayed by Accurassay Laboratories in Thunder Bay, Ontario, Canada. The samples were taken from the KRK West Property in the Beardmore-Geraldton Greenstone Belt in Northwestern Ontario, Canada.
Based upon the initial exploration program of trenching, channel sampling, geological mapping and a TEM survey covering our claim group on over 15 square miles of the KRK West Property, the Company has identified three main areas of interest.
The first area of interest is the Little Brother Claim Group, where a number of samples were taken from an area along a northern grandiorite with intermediate volcanics, which yielded visible gold occurrences. Assay results from this initial sampling program have yielded very encouraging high-grade gold assays of 9.55/oz per ton (270.74 grams/ton). Separate samples assayed from this area have similarly yielded very high-grade copper of 15.5%.
The second area of interest is close to the eastern portion of the property east of Peddle Lake. This area is the most active on the property where a number of drill collars belonging to a previous operator were drilled during the 1970's. The ground observations in the trenches and historical assessment have indicated a large disrupted zone carrying high gold and silver values.
The third area of interest is the most westerly area of the property near Musca Lake, along a continuous shear zone. The Musca Lake zone consists of a quartz flooded shear which pinches and swells along its strike length.
"These high-grade gold and copper assay results are amongst the highest values I have witnessed to date in my career," Lauren Notar, President of Source Gold Corp. comments. "We are very excited by our initial trenching and sampling program which has uncovered a number of highly mineralized areas of interest. As more samples are assayed, we look forward to better understanding the distribution of the occurrences and controls on mineralization within our claim group." The Company will continue with an aggressive exploration program, centered on the major fault lines and areas of interest which traverse our mineral claims. Accurassay Laboratories is currently processing more than 250 trench samples from the Company's three main areas of interest on the KRK West Property, and further assay results are expected within the next few weeks.
About Source Gold Corp.
Source Gold Corp. is a publicly traded junior mineral exploration company trading under the symbol SRGL.OB. The Company's corporate philosophy is to build shareholder value through the exploration and development of high quality mining and exploration projects in Canada, concentrating on gold in the prolific Beardmore-Geraldton Gold Camp in North Western Ontario.
---------------------------
(NASDAQ: MAPP - MAP Pharmaceuticals, Inc.)
LATEST NEWS!!
MAP Pharmaceuticals Appoints Alan Petro Vice President, Manufacturing and Technical Operations
MOUNTAIN VIEW, Calif., Dec 01, 2009 -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today announced the appointment of Alan Petro to the newly created position of Vice President, Manufacturing and Technical Operations. In his new role, Mr. Petro will lead the company's efforts in the area of product/process development and manufacturing in order to prepare for the potential commercialization of the company's lead product candidate, LEVADEX(TM) orally inhaled migraine therapy. Mr. Petro will report to Timothy S. Nelson, President and Chief Executive Officer of MAP Pharmaceuticals, Inc.
Mr. Petro brings to the company more than 25 years of product/process development and manufacturing operations experience within the healthcare industry. Most recently, Mr. Petro was Vice President of Supply Chain Management for Carl Zeiss Meditec, Inc. where he was responsible for both internal manufacturing and external vendor supply, as well as procurement. Mr. Petro also implemented lean manufacturing methods and developed a strategic sourcing business model. Previously, he held positions with senior and executive level responsibilities in product engineering, supply chain, manufacturing and regulatory affairs at Siemens Medical Solutions and General Electric Medical Systems.
"Al's ability to oversee clinical and commercial scale product development processes, as well as his experience in implementing manufacturing infrastructures that meet regulatory and commercial needs make him an ideal addition to our team as we move towards our goal of commercializing LEVADEX," said Timothy S. Nelson, President and Chief Executive Officer of MAP Pharmaceuticals.
Mr. Petro holds a Bachelor of Science degree in Materials and Metallurgical Engineering from the University of Michigan and a Masters of Business Administration from Marylhurst University.
About MAP Pharmaceuticals MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX orally inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.
Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.
---------------------------
(OTCBB: SNWT - San West, Inc.)
LATEST NEWS!!
San West Inc. Announces Addition to Grand Prize Buggy Giveaway
SAN DIEGO, CA, Dec 01, 2009 -- San West Inc. (OTCBB: SNWT) -- an emerging leader that designs, manufactures, sells and repairs off-road vehicles, apparel and accessories -- announced today that Buggy World has broadened its current Buggy Giveaway contest to include a Weekly Giveaway in addition to the Grand Prize Buggy Giveaway and 10 contest qualifiers.
The contest is as follows: A total of 10 qualifiers will be chosen for the grand prize, 5 from www.BuggyWorld.net and 5 from http://ksonfm.com. KSON is a San Diego based radio station whose on-air reach is in excess of 300,000 people per week. Each qualifier will receive a $100 Gift Card from Buggy World, a pair of tickets to CountryFest North and an exclusive meet-and-greet with a CountryFest artist. The winner of the Truggy will be chosen live at the spring CountryFest in May.
In an effort to increase exposure of the Buggy Giveaway and engage more consumers, Buggy World has begun to draw names on a weekly basis for a prize estimated at $100 from name brand companies such as Oakley, No Fear, Fox, and Spy. The weekly winners will be announced every Thursday on the Buggy World website and the entrants will be contacted directly to claim their prizes.
Bryan Britton, Vice President of San West Inc. and General Manager of Buggy World, said this morning on the announcement, "This last week, Buggy World's booth in the Imperial Sand Dunes was a huge hit. We had thousands of visitors to the booth, which featured some of our top-selling buggies, information on our store in Santee, California and contest registration forms for the Buggy Giveaway. Needless to say, we could not be more pleased with how productive the Vendors Row location was for us." About San West Inc.
San West designs, manufactures, sells and repairs off-road buggies, and additionally provides aftermarket performance products and accessories for off-road buggies. Products are sold via three divisions: at retail store locations, via the online store and through its growing dealer network. Buggy repair services are sold and fulfilled at the Santee, California retail location.
For further information about San West Inc. visit www.CountyImports.com, www.BuggyWorld.net and www.SanWestInc.com.
---------------------------
(NASDAQ: HLCS - Helicos BioSciences Corp.)
LATEST NEWS!!
Helicos and Mass General Hospital Publish Epigenomic Study in Nature Methods
Demonstrate ChIP Seq Using Minute Sample Amounts
CAMBRIDGE, Mass., Dec 01, 2009) -- Helicos BioSciences Corporation (NASDAQ: HLCS) today announced the publication of a landmark study by Dr. Bradley Bernstein of the Massachusetts General Hospital describing the use of Helicos' single molecule sequencing technology for the performance of genome-wide, epigenomic experiments using minute amounts of nucleic acid. The paper entitled "Chromatin Profiling by Directly Sequencing Small Quantities of Immunoprecipitated DNA" appeared in the online version of Nature Methods yesterday.
Scientists at Helicos collaborated with a team led by Dr. Bradley Bernstein, one of the foremost experts in the field of epigenomics, to demonstrate the first direct sequencing of chromatin immunoprecipitated (ChIP-Seq) nucleic acid from a small amount of starting material. This work represents an important broadening of the application of ChIP-Seq to the fields of cancer progression and developmental biology, areas of research in which sample amounts are often limiting. The new approach obviates the need for complex sample preparation and polymerase chain reaction (PCR) amplification steps that can lead to biased or incomplete results, and provides the opportunity to investigate the epigenomes of new cell types that were previously inaccessible.
"Understanding genome regulation has been hampered by the need to use millions of cells for protein-DNA interaction experiments and the requirement to amplify the DNA. Our collaboration using Helicos' single-molecule sequencing technology demonstrates the ability to minimize the use of sample and to analyze the DNA directly," stated Dr. Patrice Milos, CSO at Helicos. "By reducing the number of cells required for analysis, it is expected that Helicos' technology will help to provide a significantly higher resolution of genome regulation than previously possible." This study affirms the simplicity of the methods required for single molecule sequencing and demonstrates the enabling potential of the method for characterizing the small cell numbers required for, amongst other things, studies of early stem cell differentiation.
"We have benefited tremendously from our collaborative work with Dr. Bernstein and his colleagues," described Ron Lowy, CEO at Helicos. "They approached Helicos because they were convinced that single molecule sequencing was the only way to elucidate regulatory differences between important cell types such as embryonic stem cells and induced pluripotent stem cells. This first joint manuscript demonstrates that this is indeed the case. We believe that this marks the beginning of more breakthrough studies to come." About Helicos BioSciences: Helicos BioSciences is a life science company focused on innovative genetic analysis technologies for the research, drug discovery, and diagnostic markets. Helicos' proprietary True Single Molecule Sequencing, tSMS(TM), technology allows direct measurement of billions of strands of DNA enabling scientists to perform experiments and ask questions never before possible. Helicos is a recipient of two $1,000 genome grants and committed to providing scientists the tools to unlock the era of genomic medicine. The company's corporate headquarters are located at One Kendall Square, Building 700, Cambridge, MA 02139, and its telephone number is (617) 264-1800. For more information, please visit www.helicosbio.com.
---------------------------
(PINKSHEETS: EDWY - eDOORWAYS Corp.)
LATEST NEWS!!
eDoorways Accelerates Platform's Web 3.0 Integration With Move to Drupal
Decision to Go "Open Source" With Drupal Will Accelerate Web 3.0 Functionality
AUSTIN, TX, Dec 01, 2009 -- The eDoorways Corporation (PINKSHEETS: EDWY) has chosen to rely on Drupal, an Open Source Content Management System written in PHP and distributed under the GNU General Public License, to expedite its Web 3.0 development and delivery of SOLVE version "Beta 2.0" which will include the first incarnation of the platform's mobile applications.
"Drupal is a globally established Open Source software with over 2 million downloads since 2001," stated Gary Kimmons, Chairman & CEO of eDoorways Corporation. "Open Source is indeed the future of the Internet." "Google's cell phone operating system Android is Open Source. The White House has just shifted the whitehouse.gov website to Drupal. The Defense Department's Chief Information Officer David Wennergren has put out a memo recently saying that Open Source software can be advantageous in pursuit of the military's missions." "Given all of the current uses people have for Drupal, the caliber of the organizations moving to Open Source, and the rigorous testing Drupal has undergone in the real world, it [Drupal] is clearly suited to eDoorways' ambitions. What's even more wonderful, through Drupal, the shift to Open Source doesn't slow down our development in the slightest. In fact, Drupal will accelerate not only the development of our Web 3.0 platform but also influence the early release of the more robust versions of the first doorway." Sources close to the company indicate that this move has always been a part of the original plan for eDoorways to establish an open API environment. This gives eDoorways an affiliation with many of those developers who are working on Web 3.0. Kimmons continued, "Our plan has always been to pursue the Open Source alternative because it gives us increased flexibility and it will allow other developers to integrate into our system, bringing greater value to our service offerings. Drupal has proven itself to be a preferred software for us to use as we build our 3.0 platform and integrate each of our developing doorways into it. We are pursuing a pre-planned, step-by-step design approach that calls for this move at this time. It was originally designed into the development schedule we announced and it will play a large role in our upcoming release of SOLVE." Kimmons concluded, "Among supercomputers, 469 of the fastest 500 are running one kind of Linux or another, an Open Source operating system. eDoorways wants to capitalize on the advantages of Open Source software by building its platform with Drupal." With the company's first beta version of "SOVLE" on target for a mid December 09 release, people close to the company express much enthusiasm over Drupal as this development enhances the overall potential of additional versions of "SOLVE" slated for release during 2010: Beta 2.0, Beta 2.5, and the platform's "SOLVE" Version 3.0.
About eDoorways Corporation For more information on eDoorways Corporation and/or the "eDoorways" initiative, please e-mail a package request to info@eDoorwaysCorp.com. You can also visit our corporate website at www.eDoorwaysCorp.com, make comments via the corporate blog (www.eDoorways.wordpress.com), follow us on Twitter (http://twitter.com/edoorways), or call toll free at (866) 482-3829.
---------------------------
(PINKSHEETS: BRYN - Bryn Resources, Inc.)
LATEST NEWS!!
Bryn Resources Inc Commenced Drilling Program on Windflower Property
TORONTO, Nov 30, 2009 -- Bryn Resources Inc (PINKSHEETS: BRYN) (PINKSHEETS: BRYN.PK) is pleased to announce that the drilling program in respect of the Windflower Property has commenced with the dispatching of the drilling crew to the site this past weekend.
Bryn Resources has confirmed with its LOI partner Cayenne that drilling at the site will commence in the next few days and an announcement in respect of the particulars of the program will be released jointly between Bryn Resources and Cayenne this coming week.
The drilling program is in furtherance of the LOI entered into between Bryn Resources and Cayenne earlier this month.
Bryn Resources can also confirm that it has scheduled meetings with its representatives and those of Cayenne for today in order to confirm the details of the Joint Venture agreement to be entered into between the parties as well as negotiate other key corporate strategies the particulars of which will be released later in the week.
Bryn Resources continues to seek other opportunities in furtherance of its stated goal, which is to become an active mining exploration company, and to further increase its stable of mineralized properties in the United States and Canada.
---------------------------
About StockMarketingInc.com
StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
[ InfoTech Spotlight's Homepage ]
|
